| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Therapeutics, Molecular Targets, and Chemical Biology |
1 Neuro-Oncology Branch, National Cancer Institute and 2 National Institute of Neurological Disorders and Stroke, NIH, Bethesda, Maryland; and 3 Pathology Department, Johns Hopkins School of Medicine, Baltimore, Maryland
Requests for reprints: Howard A. Fine, Neuro-Oncology Branch, National Cancer Institute/National Institute of Neurological Disorders and Stroke, NIH, Room 225 Building 82, Bloch Building, 9030 Old Georgetown Road, Bethesda, MD 20892. Phone: 301-402-6298; Fax: 301-480-2246; E-mail: hfine{at}mail.nih.gov.
The Notch family of proteins plays an integral role in determining cell fates, such as proliferation, differentiation, and apoptosis. We show that Notch-1 and its ligands, Delta-like-1 and Jagged-1, are overexpressed in many glioma cell lines and primary human gliomas. Immunohistochemistry of a primary human glioma tissue array shows the presence in the nucleus of the Notch-1 intracellular domain, indicating Notch-1 activation in situ. Down-regulation of Notch-1, Delta-like-1, or Jagged-1 by RNA interference induces apoptosis and inhibits proliferation in multiple glioma cell lines. In addition, pretreatment of glioma cells with Notch-1 or Delta-like-1 small interfering RNA significantly prolongs survival in a murine orthotopic brain tumor model. These results show, for the first time, the dependence of cancer cells on a single Notch ligand; they also suggest a potential Notch juxtacrine/autocrine loop in gliomas. Notch-1 and its ligands may present novel therapeutic targets in the treatment of glioma.
Key Words: Notch Delta-like Jagged glioma neuro-oncology
This article has been cited by other articles:
![]() |
Y. Li, F. Guessous, Y. Zhang, C. DiPierro, B. Kefas, E. Johnson, L. Marcinkiewicz, J. Jiang, Y. Yang, T. D. Schmittgen, et al. MicroRNA-34a Inhibits Glioblastoma Growth by Targeting Multiple Oncogenes Cancer Res., October 1, 2009; 69(19): 7569 - 7576. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Li, H. Wang, C. E. Eyler, A. B. Hjelmeland, and J. N. Rich Turning Cancer Stem Cells Inside Out: An Exploration of Glioma Stem Cell Signaling Pathways J. Biol. Chem., June 19, 2009; 284(25): 16705 - 16709. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Puget, J. Grill, A. Valent, I. Bieche, C. Dantas-Barbosa, A. Kauffmann, P. Dessen, L. Lacroix, B. Geoerger, B. Job, et al. Candidate Genes on Chromosome 9q33-34 Involved in the Progression of Childhood Ependymomas J. Clin. Oncol., April 10, 2009; 27(11): 1884 - 1892. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Sivasankaran, M. Degen, A. Ghaffari, M. E. Hegi, M.-F. Hamou, M.-C. S. Ionescu, C. Zweifel, M. Tolnay, M. Wasner, S. Mergenthaler, et al. Tenascin-C Is a Novel RBPJ{kappa}-Induced Target Gene for Notch Signaling in Gliomas Cancer Res., January 15, 2009; 69(2): 458 - 465. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.J. Pierfelice, K.C. Schreck, C.G. Eberhart, and N. Gaiano Notch, Neural Stem Cells, and Brain Tumors Cold Spring Harb Symp Quant Biol, November 19, 2008; (2008) sqb.2008.73.013v2. [Abstract] [PDF] |
||||
![]() |
J. Ban, I. M. Bennani-Baiti, M. Kauer, K.-L. Schaefer, C. Poremba, G. Jug, R. Schwentner, O. Smrzka, K. Muehlbacher, D. N.T. Aryee, et al. EWS-FLI1 Suppresses NOTCH-Activated p53 in Ewing's Sarcoma Cancer Res., September 1, 2008; 68(17): 7100 - 7109. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Choi, J. T. Park, B. Davidson, P. J. Morin, I.-M. Shih, and T.-L. Wang Jagged-1 and Notch3 Juxtacrine Loop Regulates Ovarian Tumor Growth and Adhesion Cancer Res., July 15, 2008; 68(14): 5716 - 5723. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-H. Nam, H.-M. Jeon, S. Kim, M. H. Kim, Y.-J. Lee, M. S. Lee, H. Kim, K. M. Joo, D.-S. Lee, J. E. Price, et al. Activation of Notch Signaling in a Xenograft Model of Brain Metastasis Clin. Cancer Res., July 1, 2008; 14(13): 4059 - 4066. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Kefas, J. Godlewski, L. Comeau, Y. Li, R. Abounader, M. Hawkinson, J. Lee, H. Fine, E. A. Chiocca, S. Lawler, et al. microRNA-7 Inhibits the Epidermal Growth Factor Receptor and the Akt Pathway and Is Down-regulated in Glioblastoma Cancer Res., May 15, 2008; 68(10): 3566 - 3572. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. W. Purow, T. K. Sundaresan, M. J. Burdick, B. A. Kefas, L. D. Comeau, M. P. Hawkinson, Q. Su, Y. Kotliarov, J. Lee, W. Zhang, et al. Notch-1 regulates transcription of the epidermal growth factor receptor through p53 Carcinogenesis, May 1, 2008; 29(5): 918 - 925. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B Dirks Brain tumour stem cells: the undercurrents of human brain cancer and their relationship to neural stem cells Phil Trans R Soc B, January 12, 2008; 363(1489): 139 - 152. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. O'Neil, J. Grim, P. Strack, S. Rao, D. Tibbitts, C. Winter, J. Hardwick, M. Welcker, J. P. Meijerink, R. Pieters, et al. FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to {gamma}-secretase inhibitors J. Exp. Med., August 6, 2007; 204(8): 1813 - 1824. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Malecki, C. Sanchez-Irizarry, J. L. Mitchell, G. Histen, M. L. Xu, J. C. Aster, and S. C. Blacklow Leukemia-Associated Mutations within the NOTCH1 Heterodimerization Domain Fall into at Least Two Distinct Mechanistic Classes Mol. Cell. Biol., June 15, 2006; 26(12): 4642 - 4651. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Dekel, S. Metsuyanim, K. M. Schmidt-Ott, E. Fridman, J. Jacob-Hirsch, A. Simon, J. Pinthus, Y. Mor, J. Barasch, N. Amariglio, et al. Multiple Imprinted and Stemness Genes Provide a Link between Normal and Tumor Progenitor Cells of the Developing Human Kidney. Cancer Res., June 15, 2006; 66(12): 6040 - 6049. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Mungamuri, X. Yang, A. D. Thor, and K. Somasundaram Survival Signaling by Notch1: Mammalian Target of Rapamycin (mTOR)-Dependent Inhibition of p53. Cancer Res., May 1, 2006; 66(9): 4715 - 4724. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. G. Leong and A. Karsan Recent insights into the role of Notch signaling in tumorigenesis Blood, March 15, 2006; 107(6): 2223 - 2233. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Miele Notch Signaling Clin. Cancer Res., February 15, 2006; 12(4): 1074 - 1079. [Full Text] [PDF] |
||||
![]() |
S. Stylianou, R. B. Clarke, and K. Brennan Aberrant Activation of Notch Signaling in Human Breast Cancer Cancer Res., February 1, 2006; 66(3): 1517 - 1525. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Lovett-Racke, P. D. Cravens, A. R. Gocke, M. K. Racke, and O. Stuve Therapeutic Potential of Small Interfering RNA for Central Nervous System Diseases Arch Neurol, December 1, 2005; 62(12): 1810 - 1813. [Full Text] [PDF] |
||||
![]() |
I. C. Cuevas, A. L. Slocum, P. Jun, J. F. Costello, A. W. Bollen, G. J. Riggins, M. W. McDermott, and A. Lal Meningioma Transcript Profiles Reveal Deregulated Notch Signaling Pathway Cancer Res., June 15, 2005; 65(12): 5070 - 5075. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |